AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis

Nonalcoholic steatohepatitis (NASH) and associated liver fibrosis have limited therapy options. Here the authors report a novel adiponectin-based dual agonist for adiponectin receptors 1 and 2 with a longer half-life, and show that it ameliorates NASH and liver fibrosis in mouse models.

Guardado en:
Detalles Bibliográficos
Autores principales: Hongjiao Xu, Qian Zhao, Nazi Song, Zhibin Yan, Runfeng Lin, Shuohan Wu, Lili Jiang, Sihua Hong, Junqiu Xie, Huihao Zhou, Rui Wang, Xianxing Jiang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/14a1b270a4d24c8f81f31ac78a992843
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14a1b270a4d24c8f81f31ac78a992843
record_format dspace
spelling oai:doaj.org-article:14a1b270a4d24c8f81f31ac78a9928432021-12-02T17:31:24ZAdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis10.1038/s41467-020-19668-y2041-1723https://doaj.org/article/14a1b270a4d24c8f81f31ac78a9928432020-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19668-yhttps://doaj.org/toc/2041-1723Nonalcoholic steatohepatitis (NASH) and associated liver fibrosis have limited therapy options. Here the authors report a novel adiponectin-based dual agonist for adiponectin receptors 1 and 2 with a longer half-life, and show that it ameliorates NASH and liver fibrosis in mouse models.Hongjiao XuQian ZhaoNazi SongZhibin YanRunfeng LinShuohan WuLili JiangSihua HongJunqiu XieHuihao ZhouRui WangXianxing JiangNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Hongjiao Xu
Qian Zhao
Nazi Song
Zhibin Yan
Runfeng Lin
Shuohan Wu
Lili Jiang
Sihua Hong
Junqiu Xie
Huihao Zhou
Rui Wang
Xianxing Jiang
AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
description Nonalcoholic steatohepatitis (NASH) and associated liver fibrosis have limited therapy options. Here the authors report a novel adiponectin-based dual agonist for adiponectin receptors 1 and 2 with a longer half-life, and show that it ameliorates NASH and liver fibrosis in mouse models.
format article
author Hongjiao Xu
Qian Zhao
Nazi Song
Zhibin Yan
Runfeng Lin
Shuohan Wu
Lili Jiang
Sihua Hong
Junqiu Xie
Huihao Zhou
Rui Wang
Xianxing Jiang
author_facet Hongjiao Xu
Qian Zhao
Nazi Song
Zhibin Yan
Runfeng Lin
Shuohan Wu
Lili Jiang
Sihua Hong
Junqiu Xie
Huihao Zhou
Rui Wang
Xianxing Jiang
author_sort Hongjiao Xu
title AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
title_short AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
title_full AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
title_fullStr AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
title_full_unstemmed AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
title_sort adipor1/adipor2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/14a1b270a4d24c8f81f31ac78a992843
work_keys_str_mv AT hongjiaoxu adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT qianzhao adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT nazisong adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT zhibinyan adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT runfenglin adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT shuohanwu adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT lilijiang adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT sihuahong adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT junqiuxie adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT huihaozhou adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT ruiwang adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
AT xianxingjiang adipor1adipor2dualagonistrecoversnonalcoholicsteatohepatitisandrelatedfibrosisviaendoplasmicreticulummitochondriaaxis
_version_ 1718380596230619136